Evaluating PBMC Usage in Clinical Trials: A Comparative Analysis of Cell Populations with Whole Blood in Cytek Aurora
Nithianandan Selliah
Global Head, Flow Cytometry
Date/Time: June 2: 5:00-6:30pm and June 3: 5:00-6:30pm
Location: Bluebird Ballroom
Global Validation of a Flow Cytometry Panel for Clinical Trials: Detection of Ki67, Granzyme B and FoxP3 in T-, B- and NK cell Populations
Matthias De Decker
Associate Director, Flow Cytometry
Date/Time: June 2: 5:00-6:30pm and June 3: 5:00-6:30pm
Location: Bluebird Ballroom
Impact of Fixation/Permeabilization Buffers on Fluorescence Background and Marker Selection for Panel Design
Sanaz Koosha
Scientist, Flow Cytometry
Date/Time: June 2: 5:00-6:30pm and June 3: 5:00-6:30pm
Location: Bluebird Ballroom
Access the complete agenda on the event website
Flow Cytometry Services
Flow Cytometry Panels And Biomarkers
Flow Cytometry Custom Assay Development
Scientific Project Management
Download our CAR+T Drug Development eBook
In our CAR+T Drug Development eBook, Ans De Beuckelaer, Regional Head of Flow Cytometry EU, and Rowan Claeys, Clinical Biologist at Cerba Research, explore the critical role of Flow Cytometry in CAR+T clinical research. They cover its use in CAR+T trials, its value in assessing Minimal Residual Disease and multiple myeloma phenotypes, and its impact on patient treatment and targeted antigens.
Get in touch with us today today to find out how we can support your clinical trials laboratory ambitions
